Vitrolife
ISIN: SE0011205202 | Ticker: VITR | LEI: 5493001WDZMONMSPPR49
Country: Sweden
Vitrolife is committed to supporting successful treatment outcomes, through a focus on IVF and the needs of clinics and testing labs. We’ve been dedicated to IVF since 1994, when the field was still young. Today, we support customers worldwide - always with sustainability in mind. Vitrolife Group has approximately 1200 employees and the headquarter is located in Sweden with additional locations and production facilities in more than 20 countries world-wide.
In 2021, Vitrolife acquired Igenomix which is a leader in reproductive genetic testing services for IVF clinics, founded in 2011.
Together we create a global leader in reproductive health and by combining Igenomix’s portfolio of reproductive genetic testing services with Vitrolife’s best-in-class IVF device portfolio, we will be able to better support clinics and patients across the fertility journey.
1994
Served areaWorldwide
HeadquartersGustaf Werners gata 2, 42132 Västra Frölunda – Sweden
| Line item in (sek) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|
| Assets | N/A | 2,305,089,000.00 | 19,429,000,000.00 | 20,551,000,000.00 |
| Noncurrent Assets | N/A | 890,648,000.00 | 18,022,000,000.00 | 18,978,000,000.00 |
| Property Plant And Equipment | N/A | 142,113,000.00 | 333,000,000.00 | 318,000,000.00 |
| Goodwill | N/A | 403,239,000.00 | 12,995,000,000.00 | 13,874,000,000.00 |
| Other Intangible Assets | N/A | 299,481,000.00 | 4,553,000,000.00 | 4,648,000,000.00 |
| Deferred Tax Assets | N/A | 6,355,000.00 | 92,000,000.00 | 102,000,000.00 |
| Other Noncurrent Financial Assets | N/A | 24,798,000.00 | 49,000,000.00 | 36,000,000.00 |
| Noncurrent Financial Assets At Fair Value Through Profit Or Loss Mandatorily Measured At Fair Value | N/A | 14,662,000.00 | 0.00 | N/A |
| Current Assets | N/A | 1,414,442,000.00 | 1,407,000,000.00 | 1,572,000,000.00 |
| Current Tax Assets Current | N/A | 6,249,000.00 | 17,000,000.00 | 48,000,000.00 |
| Cash and cash equivalents | 689,538,000.00 | 974,000,000.00 | 630,000,000.00 | 578,000,000.00 |
| Current Prepayments And Other Current Assets | N/A | N/A | 32,000,000.00 | 47,000,000.00 |
| Equity And Liabilities | N/A | 2,305,089,000.00 | 19,429,000,000.00 | 20,551,000,000.00 |
| Equity | 1,797,628,000.00 | 2,017,000,000.00 | 15,341,000,000.00 | 16,740,000,000.00 |
| Issued Capital | N/A | 22,144,000.00 | 28,000,000.00 | 28,000,000.00 |
| Retained Earnings | N/A | 1,493,892,000.00 | 1,730,000,000.00 | 2,000,000,000.00 |
| Share Premium | N/A | 494,610,000.00 | 13,544,000,000.00 | 13,544,000,000.00 |
| Other Reserves | N/A | 1,924,000.00 | 21,000,000.00 | 1,164,000,000.00 |
| Equity Attributable To Owners Of Parent | N/A | 2,012,570,000.00 | 15,322,000,000.00 | 16,736,000,000.00 |
| Noncontrolling Interests | N/A | 4,444,000.00 | 19,000,000.00 | 4,000,000.00 |
| Liabilities | N/A | 288,076,000.00 | 4,088,000,000.00 | 3,811,000,000.00 |
| Noncurrent Liabilities | N/A | 111,062,000.00 | 3,134,000,000.00 | 3,190,000,000.00 |
| Deferred Tax Liabilities | N/A | 16,211,000.00 | 1,069,000,000.00 | 1,102,000,000.00 |
| Other Noncurrent Liabilities | N/A | 24,538,000.00 | 11,000,000.00 | 12,000,000.00 |
| Longterm Borrowings | N/A | 0.00 | 1,944,000,000.00 | 1,988,000,000.00 |
| Current Liabilities | N/A | 177,014,000.00 | 954,000,000.00 | 621,000,000.00 |
| Trade And Other Current Payables To Trade Suppliers | N/A | 25,922,000.00 | 173,081,000.00 | N/A |
| Accruals Classified As Current | N/A | N/A | 241,000,000.00 | 180,000,000.00 |
| Current Tax Liabilities Current | N/A | 8,792,000.00 | 25,000,000.00 | 27,000,000.00 |
| Other Current Liabilities | N/A | 24,695,000.00 | 59,000,000.00 | 51,000,000.00 |
| Line item in (sek) | 01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
|---|---|---|---|
| Revenue | 1,245,572,000.00 | 1,681,000,000.00 | 3,234,000,000.00 |
| Other Income | 11,492,000.00 | 10,000,000.00 | 21,000,000.00 |
| Depreciation Expense | 84,070,000.00 | 109,000,000.00 | 396,000,000.00 |
| Profit Loss From Operating Activities | 370,015,000.00 | 435,000,000.00 | 654,000,000.00 |
| Finance Income | 9,689,000.00 | 35,000,000.00 | 2,000,000.00 |
| Finance Costs | 13,514,000.00 | 10,000,000.00 | 119,000,000.00 |
| Profit Loss Before Tax | 366,191,000.00 | 460,000,000.00 | 537,000,000.00 |
| Income Tax Expense Continuing Operations | 78,325,000.00 | 116,000,000.00 | 143,000,000.00 |
| Profit (loss) | 287,865,000.00 | 344,000,000.00 | 394,000,000.00 |
| Profit Loss Attributable To Owners Of Parent | 286,845,000.00 | 341,000,000.00 | 394,000,000.00 |
| Profit Loss Attributable To Noncontrolling Interests | 1,020,000.00 | 3,000,000.00 | 0.00 |
| Line item in (sek) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|
| Profit (loss) | N/A | 287,865,000.00 | 344,000,000.00 | 394,000,000.00 |
| Adjustments For Decrease Increase In Inventories | N/A | -4,434,000.00 | -47,000,000.00 | -71,000,000.00 |
| Income Taxes Paid Refund Classified As Operating Activities | N/A | -111,375,000.00 | -144,000,000.00 | -202,000,000.00 |
| Cash Flows From Used In Operating Activities | N/A | 356,448,000.00 | 384,000,000.00 | 636,000,000.00 |
| Cash Flows From Losing Control Of Subsidiaries Or Other Businesses Classified As Investing Activities | N/A | N/A | 0.00 | -10,000,000.00 |
| Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities | N/A | 0.00 | 6,447,000,000.00 | 0.00 |
| Other Cash Receipts From Sales Of Equity Or Debt Instruments Of Other Entities Classified As Investing Activities | N/A | 0.00 | 16,000,000.00 | 0.00 |
| Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities | N/A | 243,000.00 | 0.00 | 5,000,000.00 |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | N/A | 6,769,000.00 | 25,000,000.00 | 51,000,000.00 |
| Purchase Of Intangible Assets Classified As Investing Activities | N/A | 13,317,000.00 | 38,000,000.00 | 36,000,000.00 |
| Purchase Of Other Longterm Assets Classified As Investing Activities | N/A | 374,000.00 | 0.00 | 0.00 |
| Other Inflows Outflows Of Cash Classified As Investing Activities | N/A | 0.00 | -6,000,000.00 | -20,000,000.00 |
| Cash Flows From Used In Investing Activities | N/A | -20,218,000.00 | -6,518,000,000.00 | -144,000,000.00 |
| Proceeds From Issuing Shares | N/A | 0.00 | 3,558,000,000.00 | 0.00 |
| Proceeds From Borrowings Classified As Financing Activities | N/A | 0.00 | 2,354,000,000.00 | 0.00 |
| Payments Of Lease Liabilities Classified As Financing Activities | N/A | 15,764,000.00 | 18,000,000.00 | 30,000,000.00 |
| Dividends Paid Classified As Financing Activities | N/A | 0.00 | 88,000,000.00 | 110,000,000.00 |
| Other Inflows Outflows Of Cash Classified As Financing Activities | N/A | 0.00 | 0.00 | -19,000,000.00 |
| Cash Flows From Used In Financing Activities | N/A | -26,611,000.00 | 5,749,000,000.00 | -582,000,000.00 |
| Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | N/A | 309,619,000.00 | -385,000,000.00 | -91,000,000.00 |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | N/A | -25,591,000.00 | 42,000,000.00 | 39,000,000.00 |
| Cash and cash equivalents | 689,538,000.00 | 974,000,000.00 | 630,000,000.00 | 578,000,000.00 |
Please note that some sums might not add up.
| Date | Trading entity / Person | Association | Trade type | Volume |
|---|---|---|---|---|
| 26.04.23 | Patrik Tolf | Other | Buy | SEK 535,045.25 |
| 02.02.23 | Ricardo Capella | Other | Buy | SEK 739,200.00 |
| 31.10.22 | Patrik Tolf | Other | Buy | SEK 537,000.00 |
| 28.09.22 | Ricardo Capella | Other | Buy | SEK 484,800.00 |
| 06.09.21 | Mikael Engblom | Other | Sell | SEK 359,100.00 |
| 06.09.21 | Mikael Engblom | Other | Sell | SEK 274,380.00 |
| 06.09.21 | Mikael Engblom | Other | Sell | SEK 257,500.00 |
| 06.09.21 | Mikael Engblom | Other | Sell | SEK 256,000.00 |
| 06.09.21 | Mikael Engblom | Other | Sell | SEK 249,410.00 |
| 06.09.21 | Mikael Engblom | Other | Sell | SEK 245,820.00 |
SE0011205202
LEI5493001WDZMONMSPPR49
SectorHealth Care Equipment & Services
IndustryHealth Care Equipment & Supplies
Sub-IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.